Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 29, Number 3—March 2023
CME ACTIVITY - Synopsis

Bartonella spp. Infections Identified by Molecular Methods, United States

David W. McCormick, Sara L. Rassoulian-Barrett, Daniel R. Hoogestraat, Stephen J. Salipante, Dhruba SenGupta, Elizabeth A. Dietrich, Brad T. Cookson, Grace E. Marx1Comments to Author , and Joshua A. Lieberman1
Author affiliations: Centers for Disease Control and Prevention, Fort Collins, Colorado, USA (D.W. McCormick, E.A. Dietrich, G.E. Marx); University of Washington, Seattle, Washington, USA (S.L. Rassoulian-Barrett, D.R. Hoogestraat, S.J. Salipante, D. SenGupta, B.T. Cookson, J.A. Lieberman)

Main Article

Table 1

Demographic characteristics and specimen origin for patients who had Bartonella spp. detected by PCR in study of Bartonella spp. infections identified by molecular methods, United States*

Variable No. patients† B. henselae, n = 338 B. quintana, n = 54 Other Bartonella spp.,‡ n = 28
Age, y, median (range) 415 32 (1–79) 52 (9–76) 30 (1–77)
<18 NA 122/335 (36) 2/52 (4) 10/28 (36)
18–65 NA 182/335 (54) 43/52 (83) 11/28 (39)
>65
 NA
 31/335 (9)
 7/52 (13)
 7/28 (25)
Sex 397 NA NA NA
M NA 187/321 (58) 41/50 (82) 17/26 (65)
F
 NA
 134/321 (42)
 9/50 (18)
 9/26 (35)
Specimen origin§ 361 NA NA NA
Texas 48 38/48 (79) 4/48 (8) 6/48 (13)
Washington 46 34/46 (74) 8/46 (17) 4/46 (9)
Ohio 40 36/40 (90) 0/40 (0) 4/40 (10)
California 40 22/40 (55) 16/40 (40) 2/40 (5)
Michigan 30 27/30 (90) 3/30 (10) 0/30 (0)
Florida 27 26/27 (96) 0/27 (0) 1/27 (4)
Oregon 21 17/21 (80) 2/21 (10) 2/21 (10)
Pennsylvania 11 10/11 (91) 0/11 (0) 1/11 (9)
Other¶ NA 78/98 (80) 15/98 (15) 5/98 (5)

*Values are no./total no. (%) unless otherwise indicated. NA, not applicable. †Total number of patients for each indicated variable. ‡Includes B. vinsonii (n = 2), B. clarridgeiae (n = 4), B. washoensis (n = 1), and Bartonella sp. not otherwise specified (n = 21). §Restricted to states with >10 patients who were infected with an identified Bartonella spp. to preserve anonymity. ¶Alaska (n = 4), Alabama (n = 5), Arkansas (n = 5), Colorado (n = 5), Connecticut (n = 3), District of Columbia (n = 2), Georgia (n = 5), Hawaii (n = 2), Iowa (n = 3), Idaho (n = 1), Illinois (n = 3), Indiana (n = 6), Kentucky (n = 2), Louisiana (n = 1), Massachusetts (n = 5), Maine (n = 1), Montana (n = 5), Mississippi (n = 1), North Carolina (n = 8), Nebraska (n = 5), New Hampshire (n = 2), New Jersey (n = 1), New York (n = 3), Oklahoma (n = 1), South Carolina (n = 3), Tennessee (n = 5), Utah (n = 1), Virginia (n = 5), and Wisconsin (n = 5).

Main Article

1These senior authors contributed equally to this article.

David W. McCormick, MD, MPH; Sara L. Rassoulian-Barrett, MS; Daniel R. Hoogestraat, BS, MB(ASCP); Stephen J. Salipante, MD, PhD; Dhruba SenGupta, PhD; Elizabeth A. Dietrich, PhD; Brad T. Cookson, MD, PhD; Grace E. Marx, MD, MPH; Joshua A. Lieberman, MD, PhD.

Page created: February 23, 2023
Page updated: February 23, 2023
Page reviewed: February 23, 2023
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external